A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer

Journal of Molecular Diagnostics

Volumn 16, Issue 2, 2014, Pages 229-243

  Lira, Maruja E ^a   Choi, Yoon La ^b   Lim, Sun Min ^c   Deng, Shibing ^a   Huang, Donghui ^a   Ozeck, Mark ^a   Han, Joungho ^b   Jeong, Ji Yun ^d   Shim, Hyo Sup ^d   Cho, Byoung Chul ^c   Kim, Jhingook ^b   Ahn, Myung Ju ^b   Mao, Mao ^a  

^a PFIZER INC   (United States)

^b Sungkyunkwan University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Kyungpook National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE ORDER; GENETIC TESTING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MALE; ONCOGENE PROTEINS, FUSION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC; TRANSLOCATION, GENETIC;

EID: 84894066256     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2013.11.007     Document Type: Article

References (30)

1. E.L. Kwak, Y.J. Bang, D.R. Camidge, A.T. Shaw, B. Solomon, R.G. Maki, S.H. Ou, B.J. Dezube, P.A. Janne, D.B. Costa, M. Varella-Garcia, W.H. Kim, T.J. Lynch, P. Fidias, H. Stubbs, J.A. Engelman, L.V. Sequist, W. Tan, L. Gandhi, M. Mino-Kenudson, G.C. Wei, S.M. Shreeve, M.J. Ratain, J. Settleman, J.G. Christensen, D.A. Haber, K. Wilner, R. Salgia, G.I. Shapiro, J.W. Clark, and A.J. Iafrate Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer N Engl J Med 363 2010 1693 1703
2. L.P. Chin, R.A. Soo, R. Soong, and S.H. Ou Targeting ROS1 with anaplastic lymphoma kinase inhibitors: a promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer J Thorac Oncol 7 2012 1625 1630
3. T.L. Gu, X. Deng, F. Huang, M. Tucker, K. Crosby, V. Rimkunas, Y. Wang, G. Deng, L. Zhu, Z. Tan, Y. Hu, C. Wu, J. Nardone, J. MacNeill, J. Ren, C. Reeves, G. Innocenti, B. Norris, J. Yuan, J. Yu, H. Haack, B. Shen, C. Peng, H. Li, X. Zhou, X. Liu, J. Rush, and M.J. Comb Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma PLoS One 6 2011 e15640
4. C. Li, R. Fang, Y. Sun, X. Han, F. Li, B. Gao, A.J. Iafrate, X.Y. Liu, W. Pao, H. Chen, and H. Ji Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers PLoS One 6 2011 e28204
5. D. Lipson, M. Capelletti, R. Yelensky, G. Otto, A. Parker, M. Jarosz, J.A. Curran, S. Balasubramanian, T. Bloom, K.W. Brennan, A. Donahue, S.R. Downing, G.M. Frampton, L. Garcia, F. Juhn, K.C. Mitchell, E. White, J. White, Z. Zwirko, T. Peretz, H. Nechushtan, L. Soussan-Gutman, J. Kim, H. Sasaki, H.R. Kim, S.I. Park, D. Ercan, C.E. Sheehan, J.S. Ross, M.T. Cronin, P.A. Janne, and P.J. Stephens Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies Nat Med 18 2012 382 384
6. K. Rikova, A. Guo, Q. Zeng, A. Possemato, J. Yu, H. Haack, J. Nardone, K. Lee, C. Reeves, Y. Li, Y. Hu, Z. Tan, M. Stokes, L. Sullivan, J. Mitchell, R. Wetzel, J. Macneill, J.M. Ren, J. Yuan, C.E. Bakalarski, J. Villen, J.M. Kornhauser, B. Smith, D. Li, X. Zhou, S.P. Gygi, T.L. Gu, R.D. Polakiewicz, J. Rush, and M.J. Comb Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer Cell 131 2007 1190 1203
7. V.M. Rimkunas, K.E. Crosby, D. Li, Y. Hu, M.E. Kelly, T.L. Gu, J.S. Mack, M.R. Silver, X. Zhou, and H. Haack Analysis of receptor tyrosine kinase ROS1-positive tumors in non-small cell lung cancer: identification of a FIG-ROS1 fusion Clin Cancer Res 18 2012 4449 4457
8. K. Takeuchi, M. Soda, Y. Togashi, R. Suzuki, S. Sakata, S. Hatano, R. Asaka, W. Hamanaka, H. Ninomiya, H. Uehara, Y. Lim Choi, Y. Satoh, S. Okumura, K. Nakagawa, H. Mano, and Y. Ishikawa RET, ROS1 and ALK fusions in lung cancer Nat Med 18 2012 378 381
9. K. Bergethon, A.T. Shaw, S.H. Ou, R. Katayama, C.M. Lovly, N.T. McDonald, P.P. Massion, C. Siwak-Tapp, A. Gonzalez, R. Fang, E.J. Mark, J.M. Batten, H. Chen, K.D. Wilner, E.L. Kwak, J.W. Clark, D.P. Carbone, H. Ji, J.A. Engelman, M. Mino-Kenudson, W. Pao, and A.J. Iafrate ROS1 rearrangements define a unique molecular class of lung cancers J Clin Oncol 30 2012 863 870
10. W. Pao, and K.E. Hutchinson Chipping away at the lung cancer genome Nat Med 18 2012 349 351
11. J.S. Seo, Y.S. Ju, W.C. Lee, J.Y. Shin, J.K. Lee, T. Bleazard, J. Lee, Y.J. Jung, J.O. Kim, J.Y. Shin, S.B. Yu, J. Kim, E.R. Lee, C.H. Kang, I.K. Park, H. Rhee, S.H. Lee, J.I. Kim, J.H. Kang, and Y.T. Kim The transcriptional landscape and mutational profile of lung adenocarcinoma Genome Res 22 2012 2109 2119
12. A. Drilon, L. Wang, A. Hasanovic, Y. Suehara, D. Lipson, P. Stephens, J. Ross, V. Miller, M. Ginsberg, M.F. Zakowski, M.G. Kris, M. Ladanyi, and N. Rizvi Response to cabozantinib in patients with RET fusion-positive lung adenocarcinomas Cancer Discov 3 2013 630 635
13. H.R. Kim, S.M. Lim, H.J. Kim, S.K. Hwang, J.K. Park, E. Shin, M.K. Bae, S.H. Ou, J. Wang, S.S. Jewell, D.R. Kang, R.A. Soo, H. Haack, J.H. Kim, H.S. Shim, and B.C. Cho The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma Ann Oncol 24 2013 2364 2370
14. M.E. Lira, T.M. Kim, D. Huang, S. Deng, Y. Koh, B. Jang, H. Go, S.H. Lee, D.H. Chung, W.H. Kim, E.F. Schoenmakers, Y.L. Choi, K. Park, J.S. Ahn, J.M. Sun, M.J. Ahn, D.W. Kim, and M. Mao Multiplexed gene expression and fusion transcript analysis to detect ALK fusions in lung cancer J Mol Diagn 15 2013 51 61
15. H.J. Lee, H.S. Seol, J.Y. Kim, S.M. Chun, Y.A. Suh, Y.S. Park, S.W. Kim, C.M. Choi, S.I. Park, D.K. Kim, Y.H. Kim, and S.J. Jang ROS1 receptor tyrosine kinase, a druggable target, is frequently overexpressed in non-small cell lung carcinomas via genetic and epigenetic mechanisms Ann Surg Oncol 20 2012 200 208
16. D. Matsubara, Y. Kanai, S. Ishikawa, S. Ohara, T. Yoshimoto, T. Sakatani, S. Oguni, T. Tamura, H. Kataoka, S. Endo, Y. Murakami, H. Aburatani, M. Fukayama, and T. Niki Identification of CCDC6-RET fusion in the human lung adenocarcinoma cell line, LC-2/ad J Thorac Oncol 7 2012 1872 1876
17. G.K. Geiss, R.E. Bumgarner, B. Birditt, T. Dahl, N. Dowidar, D.L. Dunaway, H.P. Fell, S. Ferree, R.D. George, T. Grogan, J.J. James, M. Maysuria, J.D. Mitton, P. Oliveri, J.L. Osborn, T. Peng, A.L. Ratcliffe, P.J. Webster, E.H. Davidson, L. Hood, and K. Dimitrov Direct multiplexed measurement of gene expression with color-coded probe pairs Nat Biotechnol 26 2008 317 325
18. V.A. Malkov, K.A. Serikawa, N. Balantac, J. Watters, G. Geiss, A. Mashadi-Hossein, and T. Fare Multiplexed measurements of gene signatures in different analytes using the NanoString nCounter assay system BMC Res Notes 2 2009 80
19. P.P. Reis, L. Waldron, R.S. Goswami, W. Xu, Y. Xuan, B. Perez-Ordonez, P. Gullane, J. Irish, I. Jurisica, and S. Kamel-Reid mRNA transcript quantification in archival samples using multiplexed, color-coded probes BMC Biotechnol 11 2011 46
20. Y. Suehara, M. Arcila, L. Wang, A. Hasanovic, D. Ang, T. Ito, Y. Kimura, A. Drilon, U. Guha, V. Rusch, M.G. Kris, M.F. Zakowski, N. Rizvi, R. Khanin, and M. Ladanyi Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions Clin Cancer Res 18 2012 6599 6608
21. A. Bhattacharjee, W.G. Richards, J. Staunton, C. Li, S. Monti, P. Vasa, C. Ladd, J. Beheshti, R. Bueno, M. Gillette, M. Loda, G. Weber, E.J. Mark, E.S. Lander, W. Wong, B.E. Johnson, T.R. Golub, D.J. Sugarbaker, and M. Meyerson Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses Proc Natl Acad Sci U S A 98 2001 13790 13795
22. M.E. Garber, O.G. Troyanskaya, K. Schluens, S. Petersen, Z. Thaesler, M. Pacyna-Gengelbach, M. van de Rijn, G.D. Rosen, C.M. Perou, R.I. Whyte, R.B. Altman, P.O. Brown, D. Botstein, and I. Petersen Diversity of gene expression in adenocarcinoma of the lung Proc Natl Acad Sci U S A 98 2001 13784 13789
23. A.H. Bild, G. Yao, J.T. Chang, Q. Wang, A. Potti, D. Chasse, M.B. Joshi, D. Harpole, J.M. Lancaster, A. Berchuck, J.A. Olson Jr., J.R. Marks, H.K. Dressman, M. West, and J.R. Nevins Oncogenic pathway signatures in human cancers as a guide to targeted therapies Nature 439 2006 353 357
24. J. Acquaviva, R. Wong, and A. Charest The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer Biochim Biophys Acta 1795 2009 37 52
25. M.M. Kulkarni Digital multiplexed gene expression analysis using the NanoString nCounter system Curr Protoc Mol Biol 2011 Chapter 25:Unit25B 10
26. A.J. Atherly, and D.R. Camidge The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers Br J Cancer 106 2012 1100 1106
27. Y. Jung, P. Kim, Y. Jung, J. Keum, S.N. Kim, Y.S. Choi, I.G. Do, J. Lee, S.J. Choi, S. Kim, J.E. Lee, J. Kim, S. Lee, and J. Kim Discovery of ALK-PTPN3 gene fusion from human non-small cell lung carcinoma cell line using next generation RNA sequencing Genes Chromosomes Cancer 51 2012 590 597
28. L. Hulea, and A. Nepveu CUX1 transcription factors: from biochemical activities and cell-based assays to mouse models and human diseases Gene 497 2012 18 26
29. B. Wasag, E. Lierman, P. Meeus, J. Cools, and P. Vandenberghe The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11) Haematologica 96 2011 922 926
30. J.F. Gainor, and A.T. Shaw Novel targets in non-small cell lung cancer: ROS1 and RET fusions Oncologist 18 2013 865 875